CIK 0001326205
- Non-accelerated filer
- Smaller reporting company
IGC Pharma, Inc.
Sign in to watch- Ticker
- IGC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- Operating
- EIN
- 202760393
- Phone
- +1 301-529-4996
- Business address
- 10224 FALLS ROAD, POTOMAC, MD, 20854
- Former names
- India Globalization Capital, Inc.
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Open-market sale Director sold 50,000 shares at an average $1.08 ($54,000)
- 4 Grant or award Vice President & PFO acquired 300,000 shares (grant or award)
- 4 Grant or award Exec. Chairman & CEO acquired 750,000 shares (grant or award)
- 4 Grant or award Manager and PAO acquired 30,000 shares (grant or award)
- 4 Open-market sale Vice President and PFO sold 116,020 shares at $2.00 ($232,040)
- 4 Open-market sale Exec. Chairman & CEO sold 50,000 shares at $1.87 ($93,260)
- 4 Open-market sale Exec. Chairman & CEO sold 200,000 shares at an average $1.04 ($207,098)
- 4 Grant or award Director acquired 215,000 shares (grant or award)
- 4 Open-market sale Vice President and PFO sold 50,000 shares at $1.10 ($55,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Exec. Chairman & CEO sold 36,000 shares at an average $1.09 ($39,162)
- 4 Open-market sale Exec. Chairman & CEO sold 50,000 shares at an average $0.76 ($37,750)
Page 4 of 8 · 156 filings